Prepared and filed by St Ives Burrups

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

October 22, 2003
Date of Report (Date of earliest event reported)

APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

 Delaware
(State or Other Jurisdiction
of Incorporation)
1-4389
 (Commission
 File No.)
06-1534213
 (IRS Employer
Identification No.)

 

301 Merritt 7
Norwalk, Connecticut 06851
(Address of Principal Executive Offices, Including Zip Code)

(203) 840-2000
(Registrant’s telephone number, including area code)

Item 7. Financial Statements and Exhibits.

(c) Exhibits.

The following exhibits are filed with this Report:

  Exhibit No.  
Description
  
         
  99.1   Press Release issued October 22, 2003, with respect to financial results for Applera and Applera’s Applied Biosystems Group.  
 
     
  99.2   Press Release issued October 22, 2003, with respect to financial results for Applera and Applera’s Celera Genomics Group.  

Item 9.   Regulation FD Disclosure

The information contained in Item 12 of this report is incorporated by reference into this Item 9.

Item 12.   Results of Operations and Financial Condition.

On October 22, 2003, Applera Corporation (“Applera”) announced financial results for Applera and its business units for the first quarter of its 2004 fiscal year. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of a press release issued on October 22, 2003, with respect to financial results for the first quarter of fiscal year 2004 of Applera and Applera’s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on October 22, 2003, with respect to financial results for the first quarter of fiscal year 2004 of Applera and Applera’s Celera Genomics Group.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  APPLERA CORPORATION
   
   
By: /s/ Dennis L. Winger               
  Dennis L. Winger
Senior Vice President and
Chief Financial Officer

 

Dated: October 22, 2003

 

EXHIBIT INDEX

Exhibit No.
  
Description
     
99.1
   Press Release issued October 22, 2003, with respect to financial results for Applera and Applera’s Applied Biosystems Group.   
   
99.2
   Press Release issued October 22, 2003, with respect to financial results for Applera and Applera’s Celera Genomics Group.